Ann: New positive interim data in Phase 2 study of SNT-5505, page-14

  1. 4 Posts.
    lightbulb Created with Sketch. 1

    "It’s sad to say those who have been on it for 5 yrs are beyond helping."

    This may be true in general, however, if I'm not mistaken - the second strongest improvement seen in TSS50 was in a patient that had been on it for 5yrs+ which, to be fair - may well represent an outlier. One 5+ yr patient also achieved SVR25 (possibly the same patient). I'm not a scientist or medical professional, so I don't know... but it may be possible that those who are 5+yrs on treatment continue to improve past the year mark on SNT-5505 (assuming they survive long enough). I certainly hope so anyway...


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.0¢
Change
-0.028(48.3%)
Mkt cap ! $48.01M
Open High Low Value Volume
5.4¢ 5.4¢ 2.9¢ $2.206M 70.64M

Buyers (Bids)

No. Vol. Price($)
14 1677985 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 1345995 12
View Market Depth
Last trade - 15.01pm 11/08/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.